ask="5.400"
ask_size="300"
average_daily_volume="504295"
bid="4.150"
bid_size="100"
book_value="3.738"
change="-0.055"
change_from_200_day_moving_average="2.896"
change_from_50_day_moving_average="0.404"
change_from_52_week_high="-7.508"
change_From_52_week_low="0.608"
change_in_percent="-1.122%"
close="4.845"
dividend_pay_date="N/A"
dividend_per_share="0.000"
dividend_yield="0.000"
earnings_per_share="-3.367"
ebitda="-41.42M"
eps_estimate_current_year="5.020"
eps_estimate_next_quarter="-0.500"
eps_estimate_next_year="-2.030"
ex_dividend_date="N/A"
float_shares="13385000"
high="4.990"
high_52_weeks="12.353"
last_trade_date="1/6/2017"
last_trade_price="4.845"
last_trade_size="100"
last_trade_time="4:00pm"
low="4.820"
low_52_weeks="4.237"
market_capitalization="109.26M"
moving_average_200_day="1.949"
moving_average_50_day="4.441"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.000"
open="4.910"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+148.544%"
percent_change_from_50_day_moving_average="+9.099%"
percent_change_from_52_week_high="-60.780%"
percent_change_from_52_week_low="+14.355%"
previous_close="4.900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.311"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="5.060"
stock_exchange="NMS"
symbol="CASC"
volume="26276"
weeks_range_52="4.237 - 12.353"
